Your session is about to expire
← Back to Search
CHEC Intervention for Caregiver Support
N/A
Waitlist Available
Led By Catherine Riffin, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with sufficient cognitive capacity to consent themselves or through a legal representative
Patients aged 65-89
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the CHEC program, which helps identify and address the needs of caregivers who accompany older patients to doctor visits. It includes a checklist for caregivers' needs and a tip sheet for doctors.
Who is the study for?
This study is for older adults aged 65-89 who are cognitively intact and their family caregivers, both of whom must speak English. Caregivers must be over 21 years old. Clinicians treating patients at the Center on Aging can also participate. Those with severe hearing or visual impairments, or without mutual consent from their care dyad counterpart, cannot join.
What is being tested?
The trial is testing CHEC (Collaborative Healthcare Encounters with Caregivers), which includes a checklist to identify caregiver needs during primary care visits for seniors, plus a Tip Sheet for clinicians to address these concerns compared to usual care practices.
What are the potential side effects?
Since this intervention involves non-medical procedures like checklists and educational materials rather than drugs or medical treatments, there are no traditional side effects associated with it.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can make my own medical decisions or have someone legally appointed to do so.
Select...
I am between 65 and 89 years old.
Select...
I speak English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptable length of CHEC, as measured by the proportion of caregivers who report that the checklist is an acceptable length
Accrual rate, as measured by the number of caregivers who complete the checklist
CHEC's ease of use, as measured by the proportion of caregivers who report that the checklist is easy to use
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Caregiver Checklist (CHEC)Experimental Treatment1 Intervention
CHEC is composed of two elements: 1) a checklist to identify the needs and concerns of unpaid/family caregivers who accompany older adults (aged 65+) to their primary care visits and 2) Tip Sheet for clinicians.
Group II: Usual careActive Control1 Intervention
Attendance at primary care appointments as usual.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for caregiver burnout often involve structured communication tools and support systems, similar to the CHEC intervention. These mechanisms work by systematically identifying the needs and concerns of caregivers through checklists and providing targeted advice and resources via tip sheets for clinicians.
This structured approach ensures that caregivers receive personalized support, which can alleviate stress, improve coping strategies, and enhance overall well-being. Addressing caregiver burnout is crucial as it directly impacts the quality of care provided to patients and the mental and physical health of the caregivers themselves.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,154,634 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,794 Previous Clinical Trials
28,192,069 Total Patients Enrolled
Catherine Riffin, PhDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
85 Total Patients Enrolled
Karl Pillemer, PhDPrincipal InvestigatorCornell University
1 Previous Clinical Trials
85 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a caregiver who goes with an older adult to their primary care visits at the Center on Aging.I am a caregiver and I am 21 years old or older.I am a clinician and I am 21 years old or older.I am a healthcare professional from a diverse racial or ethnic background.I am a caregiver of any gender and race.I can make my own medical decisions or have someone legally appointed to do so.I am a person of any gender and race.I am between 65 and 89 years old.I speak English.
Research Study Groups:
This trial has the following groups:- Group 1: Caregiver Checklist (CHEC)
- Group 2: Usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.